Abstract:Knowing the solubility data of pharmaceutical compounds in supercritical carbon dioxide (ScCO 2 ) is essential for nanoparticles formation by using supercritical technology. In this work, solubility of solid pantoprazole sodium sesquihydrate in ScCO 2 is determined and reported at 308, 318, 328 and 338 K and at pressures between 12 and 27 MPa. The solubilities are ranged between 0.0301 × 10 –4 and 0.463 × 10 –4 in mole fraction. The determined solubilities are modelled with a new model using solid–liquid equilibrium criteria and the required activity coefficient is developed using regular solution theory. The measured solubilities data are also modelled with three recent and four conventional empirical models. The recent models used are, Alwi-Garlapati (AARD = 13.1%), Sodeifian et al. (14.7%), and Tippana-Garlapati (15.5%) models and the conventional models used are Chrastil (17.54%), reformulated Chrastil (16.30%), Bartle (14.1%) and Mendenz Santiago and Teja (MT) (14.9%) models. The proposed model is correlating the data with less than 14.9% and 16.23% in terms of AARD for temperature dependent and independent cases. Among exiting models, Mendez Santiago and Teja (MT) and Alwi-Garlapati models correlate the data better than other models (corresponding AARD% and AIC c are 14.9, 13.1 and −518.89, −504.14, respectively). The correlation effectiveness of the models is evaluated in terms of Corrected Akaike's Information Criterion (AIC c ). Finally, enthalpy of solvation and vaporization of pantoprazole sodium sesquihydrate are calculated and reported. The new model proposed in this study can be used for the combination of any complex compound with any supercritical fluid.

Solubility of Racemic Paroxetine Intermediate in Supercritical Carbon Dioxide

Relationship between solubilities of EPA ester and DHA ester in supercritical carbon dioxide and their capacity factors in SFC

Response Factor Of Ibuprofen In Supercritical Carbon Dioxide

Solubilities of Dodecylpolyoxyethylene Polyoxypropylene Ether in Supercritical Carbon Dioxide

Solubility of Troeger'S Base in Supercritical Carbon Dioxide

Solubility of Oxymatrine in Supercritical Carbon Dioxide

Solubility of Acyclovir in Supercritical Carbon Dioxide

Separation Of 5,8,11,14,17-Eicodapentaenoic Acid And 4,7,10,13,16,19-Docosahemanoic Acid By Supercritical Fluid Chromatography

Enantioseparation of Paroxetine Intermediate on an Amylose-Derived Chiral Stationary Phase by Supercritical Fluid Chromatography

Enhancement Of Solubility Of Troeger'S Base In Supercritical Carbon Dioxide By Methanol

Enantioseparation of racemic paroxol on an amylose-based chiral stationary phase by supercritical fluid chromatography.

Solubilization of Oxymatrine in Water-in-Supercritical Carbon Dioxide Microemulsions

Solubilities of the Triethylene Glycol and Tripropylene Glycol Derivatives Terminated with Phosphoryl Groups in Supercritical Co2

Solubility of prazosin hydrochloride (alpha blocker antihypertensive drug) in supercritical CO2: Experimental and thermodynamic modelling

Determination of water solubility in supercritical CO2 from 313.15 to 473.15 K and from 10 to 50 MPa by in-situ quantitative Raman spectroscopy

Measurement and modeling of metoclopramide hydrochloride (anti-emetic drug) solubility in supercritical carbon dioxide

Solubility measurement and thermodynamic modeling of pantoprazole sodium sesquihydrate in supercritical carbon dioxide

Behavior of the Solubility of Puerarin in the Alcohol Solution Swollen by Supercritical Carbon Dioxide

Solubility of Pyrazine and Its Derivatives in Supercritical Carbon Dioxide

Carbamazepine solubility in supercritical CO$_2$: a comprehensive study

Enantiomeric Separation of the Key Intermediate of Paroxetine by HPLC with Chiral Stationary Phase